Rimegepant Clinical Trials
8 recruitingDrug
Phase 43Phase 33
Showing 1–8 of 8 trials
Recruiting
Phase 3
A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine
Menstrual Migraine
Pfizer723 enrolled123 locationsNCT06641466
Recruiting
Phase 3
A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine
Migraine
Pfizer200 enrolled103 locationsNCT06616194
Recruiting
Phase 4
A Study to Learn About the Safety of Taking an Additional Dose of the Medicine Rimegepant in Adults With Migraine
Acute Treatment of Migraine
Pfizer400 enrolled3 locationsNCT07609914
Recruiting
Phase 3
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
Migraine
Pfizer640 enrolled91 locationsNCT05156398
Recruiting
Observational Study to Assess Maternal, Fetal and Infant Outcomes Following Exposure to Rimegepant
Migraine
Pfizer780 enrolled1 locationNCT05046613
Recruiting
Phase 4
A Comparison of Nurtec ODT to Maxalt MLT-ODT in Adult ED Patients With Migraine Headache
Migraine
Antonios Likourezos80 enrolled1 locationNCT06473597
Recruiting
Phase 4
Acute Migraine Treatment in the ED With Gepants
Migraine Headaches
Icahn School of Medicine at Mount Sinai100 enrolled1 locationNCT06985342
Recruiting
A Registry Study on Rimegepant for the Treatment of Migraine Participants in Guangdong-Hong Kong-Macao Greater Bay Area
Migraine
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University120 enrolled1 locationNCT06221267